Anti-Obesity Drug Approved by FDA Advisory Panel

Friday, February 24, 2012

This week a Federal Drug Administration panel backed the approval of a weight loss drug called Qnexa. Strictly intended for use by clinically overweight people with BMIs over 27kg/m2, Qnexa is a combination of an already-existing weight loss drug and another drug not yet approved for weight loss. At present, many doctors use this particular combination of drugs to treat obese patients, but this approval would allow them not to go "off the label" with their prescriptions.

Art Caplan is a bioethicist.  Dr. Louis Aronne is director of the Comprehensive Weight Loss Program at New York Presbyterian Weill Cornell Medical Center.

Guests:

Dr. Louis Aronne and Dr. Arthur Caplan

Produced by:

Shia Levitt

Leave a Comment

Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.